Effectiveness of acetylcholinesterase inhibitors: diagnosis and severity as predictors of response in routine practice-Reference-Cited by-同舟云学术

Effectiveness of acetylcholinesterase inhibitors: diagnosis and severity as predictors of response in routine practice

Published:2006 Issue:8 Volume:21 Page:755-760
ISSN:0885-6230
Container-title:International Journal of Geriatric Psychiatry
language:en
Short-container-title:Int. J. Geriat. Psychiatry

Author:

Putt Rohan Van Der,Dineen Catherine,Janes David,Series Hugh,McShane Rupert

Publisher

Wiley

Subject

Psychiatry and Mental health,Geriatrics and Gerontology

Reference13 articles.

1. Rivastigmine for Dementia Associated with Parkinson's Disease

2. European Medicines Evaluation Agency. 2006. Post authorisation summary of opinion for Exelon. http://www.emea.eu.int/pdfs/human/opinion/3171806en.pdf.

3. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

4. National Institute for Clinical Excellence. 2001. Guidance on the use of Donepezil, Rivastigmine, and Galantamine for the treatment of Alzheimer's disease. Technology Appraisal Guidance-No. 19. http://www.nice.org.uk/pdf/ALZHEIMER_full_guidance.pdf.

5. National Institute for Health and Clinical Excellence. January 2006. Appraisal Consultation Document: Donepezil, Galantamine and Rivastigmine (review) and Memantine for the treatment of Alzheimer's disease. http://www.nice.org.uk.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Plasma Phosphorylated Tau With the Response to Neflamapimod Treatment in Patients With Dementia With Lewy Bodies;Neurology;2023-10-24

2. Cholinesterase Inhibitors for Treatment of Psychotic Symptoms in Alzheimer Disease and Parkinson Disease;JAMA Neurology;2023-08-01

3. Reimagining cholinergic therapy for Alzheimer’s disease;Brain;2022-03-15

4. Personalised treatment for cognitive impairment in dementia: development and validation of an artificial intelligence model;BMC Medicine;2022-02-01

5. Acute response to cholinergic challenge predicts long‐term response to galantamine treatment in patients with Alzheimer's disease;British Journal of Clinical Pharmacology;2022-01-26